On the other hand, the SNP for EGF, which was not associated with a risk of cirrhosis, was significantly associated with an increased likelihood of HCC progression in the dominant model (OR 95%CI = 1.97 (1.15–3.36), p = 0.012, for GG/AG vs. AA genotype). Here, EGF is linked to hepatocellular carcinoma.